ORAGENICS INC
For the period ended Dec 31, 2023. Filed Mar 29, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 29, 2024
OGEN$0.35+1.6%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
CONSOLIDATED BALANCE SHEETS
December 31, 2023 and 2022
| December 31, 2023 | December 31, 2022 | |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $3,483,501 | $11,426,785 |
| Prepaid expenses and other current assets | 382,273 | 2,862,738 |
| Total current assets | 3,865,774 | 14,289,523 |
| Property and equipment, net | - | 121,062 |
| Prepaid research and development expense | 1,090,750 | - |
| Operating lease right-of-use assets | 9,811 | 347,440 |
| Total assets | $4,966,335 | $14,758,025 |
| Liabilities and Shareholders’ Equity | ||
| Current liabilities: | ||
| Accounts payable and accrued expenses | $1,475,667 | $1,124,197 |
| Short-term notes payable | 312,703 | 267,640 |
| Operating lease liabilities - Current | 9,811 | 204,447 |
| Total current liabilities | 1,798,181 | 1,596,284 |
| Long-term liabilities: | ||
| Operating lease liabilities - Long Term | - | 152,439 |
| Total long-term liabilities | - | 152,439 |
| Shareholders’ equity: | ||
| Preferred stock, no par value; 50,000,000 shares authorized; 5,417,000 and 5,417,000 Series A shares, 4,050,000 and 4,050,000 Series B shares, -0- and -0- Series C shares, 7,488,197 and -0- Series F shares outstanding at December 31, 2023 and December 31, 2022, respectively | 1,592,723 | 1,592,723 |
| Common stock, $0.001 par value; 350,000,000 shares authorized; 3,080,693 and 2,024,657 shares issued and outstanding at December 31, 2023 and December 31, 2022, respectively | 3,081 | 2,025 |
| Additional paid-in capital | 207,790,604 | 196,977,071 |
| Accumulated Deficit | (206,218,254) | (185,562,517) |
| Total shareholders’ equity | 3,168,154 | 13,009,302 |
| Total liabilities and shareholders’ equity | $4,966,335 | $14,758,025 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.